Intermittent Fasting and Probiotics for Gut Microbiota Modulation in Type 2 Diabetes Mellitus: A Narrative Review.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing preclinical and clinical literature without systematic review methodology
PubMed 41515236 · doi:10.3390/nu18010119
What was done
This narrative review searched PubMed, Embase, Web of Science, and Cochrane Library through October 2025. It qualitatively synthesized preclinical and clinical studies evaluating intermittent fasting (primarily time-restricted feeding and 5:2 protocols) and multi-strain probiotics (Lactobacillus and Bifidobacterium species) in type 2 diabetes mellitus models and patients, focusing on microbiota-dependent pathways and metabolic outcomes.
What was found
Intermittent fasting consistently increased *Akkermansia muciniphila* (and variably *Faecalibacterium prausnitzii*), restored microbial circadian rhythmicity, and enhanced short-chain fatty acid and secondary bile acid production. Multi-strain probiotics modestly reduced HbA1c by -0.3% to -0.6% and lowered fasting glucose, outperforming single-strain formulations. Both interventions converged on reduced endotoxaemia and improved gut barrier integrity. Although preclinical models suggested potential synergy between the two interventions, the only direct human trial identified reported neutral results.
Why it matters
It maps shared gut-microbiome mechanisms between fasting protocols and probiotics in diabetes management. Crucially, it highlights that biological plausibility and animal synergy have not yet translated to demonstrated clinical benefit in humans.
Limits
As a narrative review, it lacks a systematic search protocol, formal study quality assessment, and quantitative meta-analysis. The total number of reviewed studies is not reported in the abstract. Evidence supporting combination therapy rests primarily on preclinical models, with human combination evidence limited to a single trial that failed to demonstrate additive efficacy.
Cited by
- supports A Nature paper showed that during fasting, the gut microbiome more actively converts bile into beneficial signaling molecules and short-chain fatty acids.